Pregled bibliografske jedinice broj: 1246719
Non-pharmacological treatments for schizophrenia in Southeast Europe: An expert survey
Non-pharmacological treatments for schizophrenia in Southeast Europe: An expert survey // International journal of social psychiatry, 68 (2021), 5; 1141-1150 doi:10.1177/00207640211023072 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1246719 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Non-pharmacological treatments for schizophrenia in
Southeast Europe: An expert survey
Autori
Injac Stevović, Lidija ; Repišti, Selman ; Radojičić, Tamara ; Sartorius, Norman ; Tomori, Sonila ; Džubur Kulenović, Alma ; Popova, Ana ; Rojnić Kuzman, Martina ; Vlachos, Ilias I. ; Statovci, Shukrije ; Bandati, Alexei ; Novotni, Antoni ; Bajraktarov, Stojan ; Panfil, Anca-Livia ; Marić, Nađa P. ; Delić, Mirjana ; Jovanović, Nikolina
Izvornik
International journal of social psychiatry (0020-7640) 68
(2021), 5;
1141-1150
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
non-pharmacological treatments ; schizophrenia ; mental health services ; expert survey ; Southeast European countries ; psychosocial interventions
Sažetak
Background: Non-pharmacological treatment for schizophrenia includes educational, psychotherapeutic, social, and physical interventions. Despite growing importance of these interventions in the holistic treatment of individuals with schizophrenia, very little is known about their availability in South-East European countries (SEE). Objective: To explore mental health care experts’ opinions of the availability of non- pharmacological treatment for people with schizophrenia in SEE. Methods: An online survey containing 11 questions was completed by one mental health expert from each of the following SEE countries: Albania, Bosnia and Herzegovina (B&H), Bulgaria, Croatia, Greece, Kosovo† , Montenegro, Moldova, North Macedonia, Romania, Serbia, and Slovenia. Data were collected on estimated rates of received nonpharmacological interventions, type of services delivering these interventions, and expert views of availability barriers. Results: In eight countries, the estimated percentage of people with schizophrenia who receive non-pharmacological treatments was below 35%. The primary explanations for the low availability of non-pharmacological treatments were: lack of human and financial resources, lack of training for clinicians, and pharmacotherapy dominance in the treatment for schizophrenia. Conclusion: Lack of personal and institutional resources and state support were identified as primary obstacles to staff training and delivering non-pharmacological treatments to people with schizophrenia on individual and systemic levels, respectively. This evidence can be used to improve holistic, evidence-based treatment for schizophrenia in the SEE countries.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE